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57 Predictors of delirium after cardiac surgery delirium: Effect of beating-heart
(off-pump) surgery f
Jan Bucerius, MD, Jan F. Gummert, MD, PhD, Michael A. Borger, MD, PhD,
Thomas Walther, MD, PhD, Nicolas Doll, MD, Volkmar Falk, MD, PhD,
Dierk V. Schmitt, MD, and Friedrich W. Mohr, MD, PhD, Leipzig, Germany
In this series of 16,184 consecutive adult patients undergoing different cardiac surgical
interventions, avoiding CPB in beating-heart surgery seemed to be beneficial with regard to the
prevalence of postoperative delirium. The increased use of this surgical technique may lead to
improved patient outcome with regard to this common complication.
65 Traction injury during minimally invasive harvesting of the saphenous vein
is associated with impaired endothelial function
Richard C. Cook, MD, Christine M. Crowley, PhD, Robert Hayden, MD, Min Gao, PhD,
Lynn Fedoruk, MD, Samuel V. Lichtenstein, MD, PhD, and Cornelis van Breemen,
DVM, PhD, Vancouver, British Columbia, Canada
Harvesting of the saphenous vein through multiple small incisions without the use of a lighted
retractor or endoscopic equipment might involve the application of substantial traction forces to
the vein. In vitro testing of human saphenous vein segments harvested by using this method
demonstrated no vasodilatory response after exposure to acetylcholine, indicating abnormal
endothelial function. Traction applied to the saphenous vein during minimally invasive surgical
harvesting might cause endothelial damage.
72 Attenuation of adhesion formation after cardiac surgery with a chymase
inhibitor in a hamster model
Yoshiharu Soga, MD, Shinji Takai, PhD, Tadaaki Koyama, MD, Yukiko Okamoto, MD, PhD,
Tadashi Ikeda, MD, PhD, Kazunobu Nishimura, MD, PhD, Mizuo Miyazaki, MD, PhD, and
Masashi Komeda, MD, PhD, Kyoto and Osaka, Japan
We have demonstrated for the first time that a specific chymase inhibitor, Suc-Val-Pro-Phep
(OPh)2, administered at the time of operation, reduces postoperative cardiac adhesion formation
in a hamster model. The chymase inhibitor not only suppressed cardiac chymase activity but
also reduced the level of TGF-1 in the pleural fluid.
79 A phase II dose-response study of hemoglobin raffimer (Hemolink) in
elective coronary artery bypass surgery
D. C. H. Cheng, MD, MSc, FRCPC, C. D. Mazer, MD, FRCPC, R. Martineau, MD,
A. Ralph-Edwards, BSc, MD, FRCSC, FACS, J. Karski, MD, J. Robblee, BSc, MBA, MD,
FRCPC, B. Finegan, MB, FFARCS(I), FRCPC, R. I. Hall, BScPharm, MD, FRCPC, FCCP,
R. Latimer, MA, MBBS, LRCP, MRCS, FRCA, and A. Vuylsteke, MD, London and Ottawa,
Ontario; Montreal, Quebec; and Halifax, Nova Scotia, Canada; and Cambridge, United
Kingdom
Hemoglobin raffimer, in a dose-response study up to 1000 mL, was not associated with any
serious adverse events in patients undergoing primary CABG with CPB and intraoperative
autologous donation. Hemoglobin raffimer may reduce the need for RBC transfusions when
used in conjunction with intraoperative autologous donation.
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